ALMIA Submits Medicare Advantage Broker Policy Comments to HHS Panel
The Alliance of Licensed Medicare Insurance Agencies filed public comments with an HHS advisory committee ahead of its November 9 meeting on Medicare Advantage broker policy.
The Alliance of Licensed Medicare Insurance Agencies (ALMIA) has submitted formal public comments to the Department of Health and Human Services Healthcare Advisory Committee, the organization announced Wednesday, as part of its continued engagement with the panel's work on strengthening Medicare Advantage broker regulations.
The comments were filed ahead of the committee's scheduled November 9 meeting, where broker compensation and oversight policies tied to Medicare Advantage plans are expected to be among the topics under review. ALMIA represents licensed agencies that sell Medicare insurance products and has positioned itself as an active voice in federal deliberations over how brokers operate within the Medicare Advantage marketplace.
Read more Democratic Congress Majority Signals Tax and Trade Policy Shifts →
Medicare Advantage, the privately administered alternative to traditional Medicare, has drawn heightened regulatory scrutiny in recent years as enrollment has surged and concerns have mounted over broker conduct, marketing practices, and plan-switching incentives. Advisory committee input can shape future rulemaking by the Centers for Medicare and Medicaid Services.
By submitting formal comments, ALMIA is seeking to ensure that the interests and operational realities of independent licensed agencies are reflected in any forthcoming policy guidance or regulatory changes stemming from the committee's recommendations. The organization's engagement signals broader industry attention to a process that could have significant downstream effects on how Medicare insurance products are marketed and sold across the country.
Continue reading at All Financial Services & Investing.
